Learning from Experience in RASwt mCRC Management: From Testing to Targeted Therapy

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Learning from Experience in RASwt mCRC Management: From Testing to Targeted Therapy

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

ASCO® 2024 Insights: "PanaMa Trial - FU/FA Maintenance Therapy With or Without Panitumumab in RAS Wild-Type mCRC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Dominik Modest

311 views

June 10, 2024

Chapters

PanaMa Trial Design & Patient Demographics

00:00

Efficacy & Survival Outcomes

02:53

Comments 0

Guidance on Incorporating Anti-EGFR Therapy in 1L CRC Practice

Ibrahim Sahin

149 views

Anti-EGFR Therapy in CRC: How to Manage Toxicities

Ibrahim Sahin

159 views

CRC Highlights From ASCO® GI 2024: Dual IO Approaches

Fight Colorectal Cancer

V. Morris

309 views

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Integrity CE

V. Lee, R. Kumar, N. Bhagat, E. Winslow

399 views

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Total Health

A. Grothey

493 views

Treating HER2-Amplified mCRC

Ibrahim Sahin

377 views

Colon Cancer Molecular Tumor Board: Elderly Patient With MSI-High Ma…

Total Health

A. Grothey

94 views

Colorectal Cancer: What's Current in Epidemiology, Risk Factors, and…

UNC Lineberger Comprehensive Cancer Center

L. Gangarosa

120 views

The Rising Tide of CRC in Younger Adults: Why Is This Happening & Wh…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

C. Eng

498 views

ESMO GI 2024 Insights: CodeBreaK 300 - Patient-Reported Tolerability…

Insights from 2024 ESMO GI Annual Meeting

J. Taieb

210 views

Integrating MMR/MSI, RAS, BRAF, and HER2 as Targetable Biomarkers In…

Marc Peeters

232 views

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

763 views

ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8…

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

585 views

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including TRANSM…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, K. Spencer, M. Cecchini

361 views

EGFR Targeted Therapy for mCRC: Differences Between Cetuximab and Pa…

Benjamin Weinberg

810 views

Treating KRAS-Mutated mCRC

Ibrahim Sahin

704 views